OBJECTIVE: Epidermal growth factor (EGF) stimulates proliferation in 3T3-L1 preadipocytes, but EGF action in differentiation is less clear. EGF promotes differentiation at concentrations <1 nM but inhibits differentiation at higher concentrations, suggesting a dual role in adipogenesis. We hypothesized that differences in EGF receptor activation and downstream signaling mediate distinct biological effects of EGF at low vs. high abundance. RESEARCH METHODS AND PROCEDURES: We compared the effects of low (0.1 nM) vs. high (10 nM) EGF on the activation of EGF receptors, proximal signaling molecules Src and Shc, and the downstream mitogen-activated protein kinase (MAPK) pathways extracellular regulated kinase (ERK) and p38 in proliferating and differentiated 3T3-L1 cells. RESULTS: Both low and high EGF activated ERK and p38 in preadipocytes. Src inhibitors PP1 and PP2 blocked ERK and p38 activation by low but not high EGF, and only high EGF increased Shc phosphorylation. Selective inhibition of the EGF receptor (EGFR) with AG1478 blocked ERK and p38 activation at both concentrations; however, selective inhibition of the ErbB2 receptor (EB2R) with AG825 or small interfering RNA (siRNA) blocked low but not high EGF activation of ERK and p38. Coimmunoprecipitation of EGFR with EB2R and Src was observed with low EGF in preadipocytes but at both concentrations in adipocytes. EB2R inhibition during differentiation decreased p38 activity and peroxisome proliferator-activated receptor gamma (PPARgamma) abundance. DISCUSSION: Our results show that EGFR homodimers mediate action of EGF at high abundance, but at low abundance, EGF promotes differentiation through EGFR/EB2R heterodimer activation of Src and p38. These results may partially explain the observations that high EGF concentrations inhibit, whereas low concentrations support, preadipocyte differentiation.
OBJECTIVE:Epidermal growth factor (EGF) stimulates proliferation in 3T3-L1 preadipocytes, but EGF action in differentiation is less clear. EGF promotes differentiation at concentrations <1 nM but inhibits differentiation at higher concentrations, suggesting a dual role in adipogenesis. We hypothesized that differences in EGF receptor activation and downstream signaling mediate distinct biological effects of EGF at low vs. high abundance. RESEARCH METHODS AND PROCEDURES: We compared the effects of low (0.1 nM) vs. high (10 nM) EGF on the activation of EGF receptors, proximal signaling molecules Src and Shc, and the downstream mitogen-activated protein kinase (MAPK) pathways extracellular regulated kinase (ERK) and p38 in proliferating and differentiated 3T3-L1 cells. RESULTS: Both low and high EGF activated ERK and p38 in preadipocytes. Src inhibitors PP1 and PP2 blocked ERK and p38 activation by low but not high EGF, and only high EGF increased Shc phosphorylation. Selective inhibition of the EGF receptor (EGFR) with AG1478 blocked ERK and p38 activation at both concentrations; however, selective inhibition of the ErbB2 receptor (EB2R) with AG825 or small interfering RNA (siRNA) blocked low but not high EGF activation of ERK and p38. Coimmunoprecipitation of EGFR with EB2R and Src was observed with low EGF in preadipocytes but at both concentrations in adipocytes. EB2R inhibition during differentiation decreased p38 activity and peroxisome proliferator-activated receptor gamma (PPARgamma) abundance. DISCUSSION: Our results show that EGFR homodimers mediate action of EGF at high abundance, but at low abundance, EGF promotes differentiation through EGFR/EB2R heterodimer activation of Src and p38. These results may partially explain the observations that high EGF concentrations inhibit, whereas low concentrations support, preadipocyte differentiation.
Authors: William D Stuart; Nicholas E Brown; Andrew M Paluch; Susan E Waltz Journal: Am J Physiol Endocrinol Metab Date: 2015-02-03 Impact factor: 4.310
Authors: Edgar Sánchez-Ramírez; Thi Phuong Lien Ung; Chiara Stringari; Lorena Aguilar-Arnal; Alejandro Alarcón Del Carmen; Ximena del Toro-Ríos; Guadalupe R Fajardo-Orduña; Lilia G Noriega; Victor A Cortés-Morales; Armando R Tovar; Juan José Montesinos; Ricardo Orozco-Solís Journal: J Cell Biol Date: 2022-10-05 Impact factor: 8.077
Authors: Michele La Merrill; David S Baston; Michael S Denison; Linda S Birnbaum; Daniel Pomp; David W Threadgill Journal: Am J Physiol Endocrinol Metab Date: 2008-10-07 Impact factor: 4.310
Authors: Valerio Cervelli; Maria G Scioli; Pietro Gentile; Elena Doldo; Elena Bonanno; Luigi G Spagnoli; Augusto Orlandi Journal: Stem Cells Transl Med Date: 2012-03-07 Impact factor: 6.940
Authors: Tingsheng Peng; Pingyu Zhang; Jeffery Liu; Theresa Nguyen; Svetlana Bolshakov; Roman Belousov; Eric D Young; Xiaoke Wang; Kari Brewer; Delores H López-Terrada; Andre M Oliveira; Alexander J Lazar; Dina Lev Journal: Lab Invest Date: 2010-11-08 Impact factor: 5.662
Authors: Silvia von der Heyde; Carolin Fromm-Dornieden; Gabriela Salinas-Riester; Tim Beissbarth; Bernhard G Baumgartner Journal: BMC Genomics Date: 2014-05-18 Impact factor: 3.969